Wuxi Biologics Cayman - ADRWXXWY
13F holders, Q3 2025 (September 30)4holders −1
1new positions
2sold out
$10.52avg. 13F price*
At the end of Q3 2025, 4 institutions reported holding Wuxi Biologics Cayman - ADR (WXXWY) in their 13F filings, down 1 from Q2 2025. 1 opened new positions and 2 sold out. The largest holders were Rhumbline Advisers ($115K), PNC Financial Services Group, Inc. ($34K) and Westside Investment Management, Inc. ($24K).
- Company
- Wuxi Biologics Cayman - ADR
- CUSIP
- 98260N108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $24K |
| Exits | 2 | $134K |
All 13F filers, Q2 2025 → Q3 2025: 2,308 shares bought and 22,168 shares sold, net −19,860 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Rhumbline Advisers | 0.00% | Reduce -8.6% | 10,954 | $115K |
| PNC Financial Services Group, Inc. | 0.00% | Add +2.5% | 3,249 | $34K |
| Westside Investment Management, Inc. | 0.00% | New | 2,229 | $24K |
| GAMMA Investing LLC | 0.00% | No change | 256 | $3K |
"% of holder's portfolio" is WXXWY's weight in each manager's 13F, not the share of Wuxi Biologics Cayman - ADR the manager owns.